CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
VNB on +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01117311
NCT01117311N/ACompleted
CompareCT.gov

The Effect of Vagal Nerve Stimulation on Enteroendocrine Secretion and Glucose Metabolism

Mayo Clinic·interventional·Posted May 5, 2010·Updated Jan 6, 2014

In Brief

A clinical study evaluating VNB on and VNB off for Type 2 Diabetes and 2 related conditions. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The overall aim of this application is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. The study proposed will examine the effect of vagal nerve stimulation on insulin secretion and action.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes, Obesity, Gastric Emptying
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Center for Research Resources (NCRR)

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 5, 2010
Enrollment StartMar 1, 2011
Primary CompletionJun 1, 2012
Study CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.2 years ago

Interventions

VNB ondevice

The implanted Vagal Nerve Blocker will be on at the time of study.

VNB offdevice

The implanted Vagal Nerve Blocker will be off at the time of study.